Prescription drug · NDA
Halog (halcinonide cream) NDC 64950-126
Halcinonide 1 mg/g · Cream · Topical · Genus Lifesciences Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 64950-126-06 | 64950012606 | 1 TUBE in 1 CARTON (64950-126-06) / 60 g in 1 TUBEMarketed from Jan 13, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Halog
- Generic name (nonproprietary)
- halcinonide cream
- Active ingredients
- Halcinonide — 1 mg/g
- Dosage form
- Cream
- Route
- Topical
- Labeler
- Genus Lifesciences Inc.
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 017556
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 64950-126_4871a969-f66c-2f83-e063-6394a90adac9SPL ID 4871a969-f66c-2f83-e063-6394a90adac9SPL set ID 484c3224-edd1-db3e-e063-6294a90abc25RxCUI 103467, 206546UNII SI86V6QNEGUPC 0364950126068
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N464950012606followed by a unit qualifier and the quantityPackage 64950-0126-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE HALOG (Halcinonide Cream, USP) 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 017556
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Halcinonide | Halcinonide 1 mg/g | CreamTopical | Sun Pharmaceutical Industries, Inc. | 57664-698 |
| Haloghalcinonide cream | Halcinonide 1 mg/g | CreamTopical | Sun Pharmaceutical Industries, Inc. | 10631-094 |